← Leaderboards
Jill E Bargonetti
Hunter College
$4,139,233
Attributed
$4,139,233
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $450.6K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,139,233 · 5
By mechanism
R01$1,781,178 · 1
SC1$1,256,880 · 1
S06$854,469 · 2
U54$246,706 · 1
Top collaborators
No co-investigators on record.
Most similar at Hunter College
Same institution · by research overlap
- Gordon Alfred Barr$5,591,276
- Jesus Alexander Angulo$17,726,170
- Patricia B Rockwell$1,697,930
- Vanya Quinones-Jenab$4,758,432
- Marie T. Filbin$9,691,997
Others in their field
Top investigators on “Dna Damage”
- Robert H Vonderheide · University Of Pennsylvania$45,163,553
- F Peter Guengerich · Vanderbilt University$33,973,148
- Aziz Sancar · University Of North Carolina Chapel Hill$31,216,731
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
- John A Tainer · Scripps Research Institute$27,554,249
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$27,391,656
Research focus
Dna DamageCell LineTp53 GeneSignal TransductionProteinsTumorMutantMalignant NeoplasmsComplexMutationPathway InteractionsMitomycinsCellsCell Culture TechniquesMediatingGenesPublishingCancer CellApoptosisP53 Gene /ProteinCell CycleCell DeathCell KillingInnovation
Grant awards (23)
Pilot Research Project: Evaluating Breast Cancer Patient Populations for Therapeutic Targeting of Aberrant p53, MDM2, MDMX, and PARP signaling$68,985
U54 · FY2025 · CA · contact PI
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer$328,101
R01 · FY2024 · CA · contact PI
Pilot Research Project: Evaluating Black and African American Breast Cancer Populations for Therapeutic Targeting of Aberrant p53, MDM2, MDMX, and PARP signaling$65,537
U54 · FY2024 · CA · contact PI
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer$338,463
R01 · FY2023 · CA · contact PI
Pilot Research Project: Evaluating Black and African American Breast Cancer Populations for Therapeutic Targeting of Aberrant p53, MDM2, MDMX, and PARP signaling$112,184
U54 · FY2023 · CA · contact PI
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer$357,342
R01 · FY2022 · CA · contact PI
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer$368,017
R01 · FY2021 · CA · contact PI
The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer$389,255
R01 · FY2020 · CA · contact PI
p53-Independent Cell Death Signaling by Mitomycin DNA Adducts$294,880
SC1 · FY2011 · CA · contact PI
p53-Independent Cell Death Signaling by Mitomycin DNA Adducts$304,000
SC1 · FY2010 · CA · contact PI
p53-Independent Cell Death Signaling by Mitomycin DNA Adducts$329,000
SC1 · FY2009 · CA · contact PI
p53-Independent Cell Death Signaling by Mitomycin DNA Adducts$329,000
SC1 · FY2008 · CA · contact PI
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members$220,035
S06 · FY2007 · GM · contact PI
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members$114,957
S06 · FY2006 · GM · contact PI
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members$111,667
S06 · FY2005 · GM
Mitomycin C (MC) and 10-decarbamoyl MC Signaling to p53 and Family Members$136,968
S06 · FY2004 · GM
MITOMYCIN SIGNALING TO AND FROM P53 DURING THE CELL CYCLE$30,384
S06 · FY2002 · GM
MITOMYCIN SIGNALING TO AND FROM P53 DURING THE CELL CYCLE$30,384
S06 · FY2002 · GM
MITOMYCIN SIGNALING TO AND FROM P53 DURING THE CELL CYCLE$30,384
S06 · FY2002 · GM
MITOMYCIN SIGNALING TO AND FROM P53 DURING THE CELL CYCLE$59,461
S06 · FY2001 · GM
MITOMYCIN SIGNALING TO AND FROM P53 DURING THE CELL CYCLE$30,384
S06 · FY2001 · GM
MITOMYCIN SIGNALING TO AND FROM P53 DURING THE CELL CYCLE$30,384
S06 · FY2001 · GM
MITOMYCIN SIGNALING TO AND FROM P53 DURING THE CELL CYCLE$59,461
S06 · FY2000 · GM